High-Dose Flu Shot Beats Standard Dose in At-Risk Patients The high-dose influenza vaccine elicits stronger immune responses in immunocompromised patients while maintaining a safety profile similar to ...

Local Anesthesia Pain: A Predictor of Post-Cesarean Pain? Pain during infiltration of local anesthesia is linked to a higher intensity of pain 24 hours after cesarean delivery and lower global health ...

Psoriasis: Presentation, Imitators, and Treatment Psoriasis is a disfiguring and often painful skin condition that affects an estimated 125 million people worldwide. Know the facts about this ...

Clinicians caution that while the app flags possible anemia, definitive diagnosis requires lab testing, patient history and ...

Kennedy Replaces Fired US CDC Panel Members, Includes Anti-vaccine Proponents U.S. Health Secretary Robert Kennedy Jr. named eight members to serve on a key panel of vaccine advisers on Wednesday, ...

Local Anesthesia Pain: A Predictor of Post-Cesarean Pain? Pain during infiltration of local anesthesia is linked to a higher intensity of pain 24 hours after cesarean delivery and lower global health ...

TOPLINE: MRI identified missed cervical spine injuries in 17% of patients with trauma who had negative CT results, prompting treatment changes in 4% of them. METHODOLOGY: Researchers conducted a ...

Canada can build successful diabetes prevention and remission programs across the country by learning from England and ...

Acute dacryocystitis is common in women, and the risk for the condition rises with age, especially in those with primary acquired nasolacrimal duct obstruction.

Ovarian Cancer: 5 Things to Know Early symptoms of ovarian cancer can be vague and nonspecific, but it is one of the leading causes of gynecologic cancer deaths. Keep alert with these five things to ...

Without Measles Herd Immunity, Vulnerable Kids Are at Risk With a 97% effective vaccine, 3% of children rely on ‘halos’ of herd immunity protection, clinicians say. Declining vaccination rates will ...

A post hoc analysis of the BEATcc trial showed that atezolizumab plus chemotherapy and bevacizumab provided clinical benefit ...